BIORBYT LTD. Non-Antibody Products — page 4 of 5
Non-Antibody Products
Page 4,774 of 5,306
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Skullcapflavone II | MW: 374.345 | 5 mg | orb757961 | More Info |
| Skullcapflavone II | Purity > 98%. MW: 374.4 | 10 mg | orb508165 | More Info |
| Skullcapflavone II | Purity 99.78%. MW: 374.35 | 5 mg, 50 mg, 25 mg, 10 mg, 1 mg | orb1297591 | More Info |
| Skullcapflavone II | Skullcapflavone II is a flavonoid derived from Scutellaria baicalensis, a… | 10 mg, 5 mg | orb1219416 | More Info |
| Skullcap Standards Kit | n/a | 1 kit | orb322046 | More Info |
| SL 0101-1 | Purity > 98%. MW: 516.45 | 100 mg, 50 mg, 25 mg, 10 mg | orb1183569 | More Info |
| SL-01 | Purity > 98% (TLC); NMR (Conforms). MW: 331.8 | 50 mg | orb1713940 | More Info |
| SL-01 | Purity > 98%. MW: 331.8 | 250 mg, 50 mg | orb340301 | More Info |
| SL-017 | Purity 98.00%. MW: 598.652 | 5 mg | orb1695202 | More Info |
| SL-25.1188 | Purity 98.00%. MW: 374.31 | 50 mg, 100 mg, 5 mg | orb1699285 | More Info |
| SL251188 | Purity > 98%. MW: 374.31 | 50 mg, 25 mg, 10 mg, 5 mg | orb1183426 | More Info |
| SL327 | Purity 99.74%. MW: 335.35 | 50 mg, 10 mg, 5 mg | orb1305134 | More Info |
| SL327 | SL-327 is a cell-permeable vinylogous cyanamide that acts as a selective i… | 1 g, 100 mg, 250 mg | orb341658 | More Info |
| SL-327 | SL327 is a selective inhibitor for MEK1 / 2 with IC50 of 0.18 µM / 0… | 200 mg, 100 mg, 50 mg, 25 mg, 10 mg, 5 mg | orb1222389 | More Info |
| SL-327 | n/a | 10 mg, 25 mg, 50 mg | orb1895787 | More Info |
| SL-651498 | Purity 98.00%. MW: 389.42 | 5 mg, 50 mg, 100 mg | orb1699284 | More Info |
| SL-870495 | Purity 98.00%. MW: 527.62 | 50 mg, 100 mg, 5 mg | orb1699283 | More Info |
| SL910102 | Purity > 98%. MW: 490.6 | 50 mg, 10 mg, 5 mg, 1 mg | orb1182824 | More Info |
| SL 0101-1 | MW: 516.45 | 25 mg | orb1971953 | More Info |
| SL251188 | MW: 374.31 | 50 mg | orb1971594 | More Info |
| SL910102 | MW: 490.6 | 5 mg | orb1970090 | More Info |
| SLA | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598874 | More Info |
| SlaI | Isoschizomers: BssHI, PaeR7I, Sfr274I, TliI, XhoI | 5000 Units | orb1734819 | More Info |
| SlaI | Isoschizomers: BssHI, PaeR7I, Sfr274I, TliI, XhoI | 5 x 5000 Units | orb94015 | More Info |
| SLAIN1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb601702 | More Info |
| SLAIN1 Human Over-expression Lysate | SLAIN1 HEK293T cell transient overexpression lysate (as WB positive contro… | 20 ug | orb1373209 | More Info |
| SLAIN1 Human Over-expression Lysate | Transient overexpression lysate of SLAIN motif family, member 1 (SLAIN1),… | 100 ug | orb1352873 | More Info |
| SLAIN1 Peptide | n/a | 0.05 mg | orb1232278 | More Info |
| SLAIN2 Peptide | n/a | 0.05 mg | orb1232702 | More Info |
| SLAIN2 Peptide | n/a | 0.1 mg | orb1236244 | More Info |
| SLAIN1 siRNA (Human) | siRNA to inhibit SLAIN1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1853569 | More Info |
| SLAIN2 siRNA (Human) | siRNA to inhibit SLAIN2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1856683 | More Info |
| SLAIN1 siRNA (Mouse) | siRNA to inhibit SLAIN1 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1838569 | More Info |
| SLAIN2 siRNA (Mouse) | siRNA to inhibit SLAIN2 expression using RNA interference. Purity > 97% | 30 nmol, 15 nmol | orb1839724 | More Info |
| SLAM/CD150 Protein, Human, Recombinant (His) | Purity 98.00%. MW: approxiamtely 25.8 kDa | 100 ug | orb1958597 | More Info |
| SLAM/CD150 Protein, Rat, Recombinant (hFc) | Purity 98.00%. MW: approxiamtely 51.3 kDa | 100 ug | orb1958943 | More Info |
| SLAM/CD150 Protein, Rat, Recombinant (His) | Purity 98.00%. MW: approxiamtely 17.4 kDa | 100 ug | orb1956047 | More Info |
| SLAMF1 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598940 | More Info |
| SLAMF1 | n/a | 10 ug | orb528162 | More Info |
| SLAMF6 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb597841 | More Info |
| SLAMF7 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb597842 | More Info |
| SLAMF8 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb597843 | More Info |
| SLAMF7/CD319 Protein, Human, Recombinant (hFc) | Purity 98.00%. MW: approxiamtely 49.1 kDa | 100 ug | orb1954468 | More Info |
| SLAMF7/CD319 Protein, Human, Recombinant (hFc), Biotinylated | Purity 98.00%. MW: approxiamtely 49.1 kDa | 20 ug | orb1954325 | More Info |
| SLAMF7/CD319 Protein, Human, Recombinant (His) | Purity 95.10%. MW: approxiamtely 23.8 kDa | 100 ug | orb1958159 | More Info |
| SLAMF7/CD319 Protein, Human, Recombinant (His), Biotinylated | Purity 98.00%. MW: approxiamtely 23.8 kDa | 20 ug | orb1954324 | More Info |
| SLAMF7/CD319 Protein, Mouse, Recombinant (His) | Purity 98.00%. MW: approxiamtely 23.7 kDa | 100 ug | orb1958414 | More Info |
| SLAMF7/CRACC/CD319 Protein, Cynomolgus, Recombinant (His) | Purity 98.00%. The protein has a predicted MW of 23.55 kDa. Due to glycosy… | 100 ug | orb1959680 | More Info |
| SLAMF7/CRACC/CD319 Protein, Human, Recombinant (His & Avi) | Purity 98.00%. The protein has a predicted MW of 25.3 kDa. Due to glycosyl… | 100 ug | orb1960658 | More Info |
| SLAMF7 / CRACC / CD319 Recombinant Protein | SLAMF7 / CRACC / CD319 Recombinant Protein. Purity > 95% as determined by… | 0.1 mg | orb1231171 | More Info |
| SLAMF7 Human Over-expression Lysate | SLAMF7 HEK293T cell transient overexpression lysate (as WB positive contro… | 20 ug | orb1376839 | More Info |
| SLAMF7 Human Over-expression Lysate | Transient overexpression lysate of SLAM family member 7 (SLAMF7) | 100 ug | orb1356504 | More Info |
| SLAMF8 Human Over-expression Lysate | SLAMF8 HEK293T cell transient overexpression lysate (as WB positive contro… | 20 ug | orb1370197 | More Info |
| SLAMF8 Human Over-expression Lysate | Transient overexpression lysate of SLAM family member 8 (SLAMF8) | 100 ug | orb1349860 | More Info |
| SLAMF9 Human Over-expression Lysate | SLAMF9 HEK293T cell transient overexpression lysate (as WB positive contro… | 20 ug | orb1372390 | More Info |
| SLAMF9 Human Over-expression Lysate | Transient overexpression lysate of SLAM family member 9 (SLAMF9), transcri… | 100 ug | orb1352054 | More Info |
| SLAMF8 Immunizing peptide | n/a | 100 ug | orb737574 | More Info |
| SLAMF6/NTB-A Protein, Cynomolgus, Recombinant (His) | Purity 98.00%. The protein has a predicted MW of 23.98 kDa. Due to glycosy… | 100 ug | orb1960251 | More Info |
| SLAMF6/NTB-A Protein, Human, Recombinant (His & Avi) | Purity 98.00%. The protein has a predicted MW of 26 kDa. Due to glycosylat… | 100 ug | orb1960661 | More Info |
| SLAMF6/NTB-A Protein, Mouse, Recombinant (His) | Purity 98.00%. The protein has a predicted MW of 24.03 kDa. Due to glycosy… | 100 ug | orb1959758 | More Info |
| SLAMF1 Peptide | n/a | 0.05 mg | orb1232408 | More Info |
| SLAMF2 Peptide | n/a | 0.05 mg | orb1232407 | More Info |
| SLAMF3 Peptide | n/a | 0.05 mg | orb1232406 | More Info |
| SLAMF4 Peptide | n/a | 0.05 mg | orb1232405 | More Info |
| SLAMF8 Peptide | n/a | 0.1 mg | orb1235088 | More Info |
| SLAMF9 Peptide | n/a | 0.05 mg | orb1232430 | More Info |
| SLAMF6 Protein, Human, Recombinant | Purity 98.00%. MW: approxiamtely 23.9 kDa | 100 ug | orb1955918 | More Info |
| SLAMF6 Protein, Human, Recombinant (hFc) | Purity 98.00%. MW: approxiamtely 50.1 kDa | 100 ug | orb1955952 | More Info |
| SLAMF2 Protein, Human, Recombinant (hFc & His) | Purity 98.00%. MW: 71 KDa, reducing conditions | 10 ug | orb1962093 | More Info |
| SLAMF3 Protein, Human, Recombinant (His) | Purity 98.00%. MW: 75 KDa, reducing conditions | 10 ug | orb1961890 | More Info |
| SLAMF5 Protein, Human, Recombinant (His) | Purity 98.00%. MW: 35-43 KDa, reducing conditions | 10 ug | orb1962009 | More Info |
| SLAMF6 Protein, Human, Recombinant (His) | Purity 98.00%. MW: approxiamtely 24.3 kDa | 100 ug | orb1957740 | More Info |
| SLAMF8 Protein, Human, Recombinant (His) | Purity 98.00%. MW: 34 KDa, reducing conditions | 10 ug | orb1960975 | More Info |
| SLAMF1 Protein, Human, Recombinant (His & Avi), Biotinylated | Purity 98.00%. MW: 45-65 KDa, reducing conditions | 20 ug | orb1962015 | More Info |
| SLAMF5 Protein, Human, Recombinant (His & Avi), Biotinylated | Purity 98.00%. MW: 40-50 KDa, reducing conditions | 20 ug | orb1962010 | More Info |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Return to Profile